1-6 of 6
Masahiro Oura
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Steric Hindrance By APRIL in Binding of BCMA-Directed Bispecific Antibodies: A Novel Refractory Mechanism of BCMA-Directed Immunotherapies in Multiple Myeloma

Takeshi Harada, Yusuke Inoue, Asuka Oda, Jumpei Teramachi, Yusaku Maeda, Ryohei Sumitani, Masahiro Oura, Kimiko Sogabe, Hikaru Yagi, Shiro Fujii, Shingen Nakamura, Hirokazu Miki, Kumiko Kagawa, Shuji Ozaki, Ken-ichi Matsuoka, Masahiro Abe
Journal: Blood
Blood (2024) 144 (Supplement 1): 1884.
https://doi.org/10.1182/blood-2024-204524
Published: 2024
Journal Articles

Identification of Light Chain Amyloidosis-Associated Single Nucleotide Variants in Japanese People

Shingen Nakamura, Youichi Sato, Yusaku Maeda, Ryohei Sumitani, Masahiro Oura, Kimiko Sogabe, Hikaru Yagi, Shiro Fujii, Takeshi Harada, Masahiro Abe, Hirokazu Miki, Ken-ichi Matsuoka
Journal: Blood
Blood (2024) 144 (Supplement 1): 6867.
https://doi.org/10.1182/blood-2024-193277
Published: 2024
Journal Articles

Development of a Novel and Rapid Diagnostic Technique for Cardiac Amyloidosis Using Raman Spectroscopy

Hirokazu Miki, Hiroki Takanari, Shin-ichro Yanagiya, Mizuki Yoshimoto, Yusaku Maeda, Ryohei Sumitani, Masahiro Oura, Kimiko Sogabe, Hikaru Yagi, Mamiko Takahashi, Takeshi Harada, Shiro Fujii, Shingen Nakamura, Yoshimi Bando, Koichi Tsuneyama, Masahiro Abe, Ken-ichi Matsuoka
Journal: Blood
Blood (2024) 144 (Supplement 1): 4683.
https://doi.org/10.1182/blood-2024-206982
Published: 2024
Journal Articles

Novel Therapeutic Rationale for Targeting HDAC1 and PIM2 in Multiple Myeloma

Takeshi Harada, MD PhD, Asuka Oda, Hiroto Ohguchi, MD PhD, Yohann Grondin, PhD, Hirofumi Tenshin, DDS, PhD, Masahiro Hiasa, DDS, PhD, Jumpei Teramachi, Masahiro Oura, MD, Kimiko Sogabe, MD, Shiro Fujii, MD PhD, Shingen Nakamura, MD PhD, Hirokazu Miki, MD PhD, Kumiko Kagawa, MD PhD, Shuji Ozaki, MD PhD, Teru Hideshima, MD PhD, Kenneth C. Anderson, MD, Masahiro Abe, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3111.
https://doi.org/10.1182/blood-2019-127679
Published: 2019
Journal Articles

The Critical Role of HDAC1-IRF4-Pim-2 Axis in Myeloma Cell Growth and Survival: Therapeutic Impacts of Targeting the HDAC1-IRF4-Pim-2 Axis

Takeshi Harada, MD PhD, Asuka Oda, PhD, Yohann Grondin, PhD, Jumpei Teramachi, DDS, PhD, Ariunzaya Bat-Erdene, MD PhD, Masami Iwasa, MD, Masahiro Oura, MD, Shingen Nakamura, MD PhD, Kumiko Kagawa, MD PhD, Yasunobu Okamoto, MD, Kimiko Sogabe, MD, Shiro Fujii, MD, Hirokazu Miki, MD PhD, Shuji Ozaki, MD PhD, Teru Hideshima, MD PhD, Kenneth C. Anderson, MD, Masahiro Abe, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1939.
https://doi.org/10.1182/blood-2018-99-114086
Published: 2018
Journal Articles

Survival Outcome of Salvage Therapy with Second-Generation Novel Agents in Patients with Relapsed and Refractory Multiple Myeloma in Routine Clinical Practice

Shuji Ozaki, MD PhD, Takeshi Harada, MD PhD, Kengo Udaka, MD, Etsuko Sekimoto, MD PhD, Hironobu Shibata, MD PhD, Toshio Shigekiyo, MD PhD, Hikaru Yagi, MD, Yasunobu Okamoto, MD, Kimiko Sogabe, MD, Masahiro Oura, MD, Shiro Fujii, MD, Shingen Nakamura, MD PhD, Hirokazu Miki, MD PhD, Kumiko Kagawa, MD PhD, Masahiro Abe, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5577.
https://doi.org/10.1182/blood-2018-99-115818
Published: 2018